Alleima (ALLEI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Oct, 2025Executive summary
Geopolitical and macroeconomic uncertainty, especially in Europe and the Americas, continues to impact demand, with customers delaying investments and a wait-and-see attitude prevailing.
Despite challenging conditions, diversified exposure and solid backlogs in oil & gas, nuclear, and medical segments support near-term visibility and reduce volatility.
Targeted cost-saving and restructuring initiatives are being implemented, aiming for SEK 200 million in annual savings at a one-off cost of SEK 400 million and a reduction of about 250 FTEs.
Sustainability remains a focus, with high recycled steel usage, record-low accident frequency, EcoVadis Gold Medal, and SBTi validation.
Strong financial position and ongoing growth initiatives support continued execution of strategy.
Financial highlights
Revenues at SEK 4,222 million, flat organic growth compared to last year; Kanthal and strip grew, tube declined.
Adjusted EBIT margin declined to 4.7% from 7% last year, with adjusted EBIT at SEK 197 million, impacted by weak markets, maintenance shutdown, and FX headwinds.
Reported EBIT margin dropped to 3% from 6.5% last year, affected by negative metal price effects and currency movements.
Adjusted EPS for the quarter was SEK 0.56 per share, down from 1.02 year-over-year.
Free operating cash flow was SEK 285 million, lower than last year due to lower operating profit and higher CapEx.
Outlook and guidance
Market and geopolitical uncertainty expected to persist into Q4, with no fast recovery anticipated.
One-off restructuring cost of SEK 400 million to impact Q4 results; annual cost savings of SEK 200 million expected, with half the run rate by end of Q2 2026 and full effect by year-end.
CapEx guidance for full year maintained at SEK 1.2 billion.
Currency headwinds expected to negatively impact Q4 EBIT by SEK 150 million, with half mitigated by hedges.
Normalized tax rate for 2025 expected in the 23%-25% range.
Latest events from Alleima
- Flat organic growth, strong cash flow, and improved EBIT amid robust market sentiment.ALLEI
Q2 20243 Feb 2026 - Flat 2025 revenue, strong cash flow, and SEK 2.50 dividend amid FX and market headwinds.ALLEI
Q4 20252 Feb 2026 - Organic revenue up 3%, EBIT margin 7%, with strong nuclear and medical investments.ALLEI
Q3 202419 Jan 2026 - Stable earnings, strong cash, and growth in key segments despite mixed market demand.ALLEI
Q4 20249 Jan 2026 - Strong Q1 growth and margins, but Q2 faces currency and metal price headwinds.ALLEI
Q1 202528 Dec 2025 - Profitability held up despite revenue declines and market uncertainty, with resilient margins.ALLEI
Q2 202516 Nov 2025 - Profitable growth, innovation, and sustainability drive expansion in high-value segments.ALLEI
CMD 20258 Nov 2025